AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Brilinta / Brilique (ticagrelor) by Year
Brilinta / Brilique (ticagrelor) — Emerging Markets product sales ($M) ($M)
AstraZeneca Brilinta / Brilique (ticagrelor): $273M in FY2025, down 7.1% from a year earlier.
Where the FY2025 figure comes from
“|| Brilinta | 823 | (38) | (38) | 393 | (48) | 273 | (7) | (7) | 147 | (45) | (46) | 10 | (51) | (48)”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Brilinta / Brilique (ticagrelor) — Emerging Markets product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 273 | -7.1% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 294 | +3.2% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 285 | -0.3% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 286 | -12.8% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 328 | -28.9% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 461 | – | Form 6-K FY2020Q4 Earnings Release ↗ |
Breakdown
What makes up brilinta / Brilique (ticagrelor)
Cite this data
StockData. (2026). AstraZeneca Brilinta / Brilique (ticagrelor) ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-brilinta-em
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.